Real-World study tracks elidel use in asian kids with eczema
NCT ID NCT06052995
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is observing how Elidel cream (pimecrolimus) is actually used in South and East Asian children aged 3 months to 12 years with mild to moderate atopic dermatitis (eczema). Researchers are tracking changes in eczema severity, itching, and sleep loss over the treatment period. The goal is to gather real-world data on how well the cream works in this specific population.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pimecrolimus (Elidel cream)
- What this could lead to
- If successful, this study could provide real-world evidence on how well Elidel works for eczema in South and East Asian children, helping doctors tailor treatment.
- What could go wrong
- This is an observational study, not a controlled trial, so results may be less reliable. It only looks at how the drug is already being used, not testing a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD TO MODERATE ATOPIC DERMATITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Viatris Clinical Site
Kuala Lumpur, Kuala Lumpur, 50300, Malaysia
-
Viatris Clinical Site
Ipoh, Perak, 31400, Malaysia
-
Viatris Clinical Site
Petaling Jaya, Selangor, 47810, Malaysia
-
Viatris Clinical Site
Kaohsiung City, Niaosong, 83301, Taiwan
-
Viatris Clinical Site
Taichung, Taiwan, 402306, Taiwan
-
Viatris Clinical Site
Taichung, Xitun, 40705, Taiwan
-
Viatris Clinical Site
Phu Wiang, Changwat Khon Kaen, 40002, Thailand
-
Viatris Clinical Site
Khlong Luang, Changwat Pathum Thani, 12120, Thailand
-
Viatris Clinical Site
Bangkok, 10330, Thailand
More trials for these conditions
Other studies related to the condition(s) this trial covers.